Change in management
ORPHAZYME A/S The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless,...
Orphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark.
90 | |
90 | |
- | |
90 | |
90 | |
90-130 | |
6 396 K | |
41 712 | |
36 193 K | |
0.079 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ORPHAZYME A/S The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless,...
ORPHAZYME A/S Company announcement Orphazyme A/S No. 8/2023Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 Copenhagen, Denmark, May 17, 2023 – Orpha...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: